Table 1.
Clinical data of 109 patients with FSGS/MCD included in the analysis of INF2
| Characteristic | Group | Number/Value |
|---|---|---|
| Diagnosis | FSGS | 77 (70.6%) |
| MCD | 32 (29.4%) | |
| Sex | Male | 51 (46.8%) |
| Female | 58 (53.2%) | |
| Family history | Positive | 19 (17.4%) |
| Negative | 90 (82.6%) | |
| NS at the time of diagnosis | Yes | 78 (71.6%) |
| No | 31 (28.4%) | |
| Effect of corticosteroid therapy | Sensitive | 34 (31.2%) |
| Resistant | 41 (37.6%) | |
| No therapy | 34 (31.2%) | |
| Mean age at the time of diagnosis | Years | 41.44 ± 18.91 |
| Mean proteinuria at the time of diagnosis | All: Grams/24 h | 5.67 ± 4.64 |
| FSGS: Grams/24 h | 4.99 ± 4.14 | |
| MCD: Grams/24 h | 7.42 ± 5.32 | |
| Mean serum albumin level at the time of diagnosis | All: Grams/Litre | 28.05 ± 9.48 |
| FSGS: Grams/Litre | 30.36 ± 9.1 | |
| MCD: Grams/Litre | 22.15 ± 7.67 | |
| Average serum creatinine level at the time of diagnosis | All: μmol/Litre | 109.52 ± 61.26 |
| FSGS: μmol/Litre | 112.05 ± 52.21 | |
| MCD: μmol/Litre | 103.31 ± 78.91 |
Data are presented by mean ± SD or number (percentage)
FSGS Focal segmental glomerulosclerosis, MCD Minimal change disease, NS Nephrotic syndrome (defined as presence of proteinuria ≥3 g/24 h plus serum albumin level ≤ 30 g/L)